|
|
|
|
|
Session 52
Poster Presentations HIV Vaccines Using Viral Vectors Session Day and Time: Thursday 1:30 - 3:30 pm Room: Hall D |
Background: Attenuated pox viruses such as Modified Vaccinia
Ankara (MVA) have generated significant interest as vectors for HIV vaccines. However,
many features of MVA’s interaction with the host immune system are poorly
understood. In particular, the range of cellular targets within the immune
system and the immediate effects of the infection on these cells have not been
clearly delineated. Knowledge of these viral targets and effects will
facilitate the design of rational pox virus-based HIV vaccine candidates.
Methods: Using recombinant MVA and Vaccinia Virus (VV) expressing
GFP, we have determined the cellular tropism of MVA and VV in primary human
PBMC and cultured antigen presenting cells, by both confocal microscopy and
flow cytometry. To characterize infected cells, flow cytometric analyses for
expression of viral gene products, cell surface phenotypic markers, and
apoptosis were performed.
Results: In contrast to widespread beliefs, the tropism of MVA
and VV is very limited for primary human targets. These viruses readily infect
dendritic cells (DCs, both ex vivo- and in vivo-derived), an observation that
has favorable implications for MVA as a vaccine vector. MVA and VV were also
found to infect monocytes/macrophages, a smaller fraction of B-cells, and
virtually no resting T-cells. Interestingly, activation of T-cells renders them
highly susceptible to infection. MVA/VV-infected activated T-cells express gene
products from both early and late stages of the virus life cycle. In contrast,
infected DCs only express early viral genes, do not mature following infection,
and die via apoptosis. These features of DC infection may thwart their direct
antigen presenting capability, and engender speculation regarding the
generation of cellular immune responses following MVA vaccination.
Conclusions: Our findings demonstrate that the range of
cells susceptible to MVA/VV infection is highly restricted to key populations
involved in the generation of immune responses, such as DCs, monocytes/macrophages,
and activated T-cells (with variable B-cell infection). The described features
of MVA and VV cellular tropism may influence early virus dissemination
following primary infection and the generation of immune responses following
vaccination with pox virus vectors. Importantly, this characterization of the
consequences of infection on DCs suggests promising modifications to MVA-based
HIV vaccines that should serve to enhance their immunogenic potential.